Immunotherapy Reshapes Advanced Liver Cancer Care in Europe, but Access Lags Behind
Liver cancer has long been one of oncology’s most stubborn challenges, and hepatocellular carcinoma (HCC) — the dominant primary liver malignancy — has historically resisted...















